Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors

Bibliographic Details
Title: Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors
Authors: Xiaoqin Ji, Wanrong Jiang, Jiasheng Wang, Bin Zhou, Wei Ding, Shuling Liu, Hua Huang, Guanhua Chen, Xiangdong Sun
Source: Frontiers in Immunology, Vol 13 (2023)
Publisher Information: Frontiers Media S.A., 2023.
Publication Year: 2023
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: cancer, metastatic tumor, high-dose radiotherapy, low-dose radiotherapy, immunotherapy, Immunologic diseases. Allergy, RC581-607
More Details: Radiotherapy is one of the mainstays of cancer treatment. More than half of cancer patients receive radiation therapy. In addition to the well-known direct tumoricidal effect, radiotherapy has immunomodulatory properties. When combined with immunotherapy, radiotherapy, especially high-dose radiotherapy (HDRT), exert superior systemic effects on distal and unirradiated tumors, which is called abscopal effect. However, these effects are not always effective for cancer patients. Therefore, many studies have focused on exploring the optimized radiotherapy regimens to further enhance the antitumor immunity of HDRT and reduce its immunosuppressive effect. Several studies have shown that low-dose radiotherapy (LDRT) can effectively reprogram the tumor microenvironment, thereby potentially overcoming the immunosuppressive stroma induced by HDRT. However, bridging the gap between preclinical commitment and effective clinical delivery is challenging. In this review, we summarized the existing studies supporting the combined use of HDRT and LDRT to synergistically enhance antitumor immunity, and provided ideas for the individualized clinical application of multimodal radiotherapy (HDRT+LDRT) combined with immunotherapy.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-3224
Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2022.1106644/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2022.1106644
Access URL: https://doaj.org/article/c3ecd68ca8b04f7191dd092cd87f4f4c
Accession Number: edsdoj.3ecd68ca8b04f7191dd092cd87f4f4c
Database: Directory of Open Access Journals
More Details
ISSN:16643224
DOI:10.3389/fimmu.2022.1106644
Published in:Frontiers in Immunology
Language:English